We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




HLA Primer Sets Achieve High- and Medium-Resolution Genotyping

By LabMedica International staff writers
Posted on 05 Apr 2011
New HLA Primer Sets achieve high- and medium-resolution genotyping of class I and class II loci of the Human Leukocyte Antigen (HLA) genes.

Introduced by 454 Life Sciences (Branford, CT, USA), a Roche Company, the new GS GType New HLA Primer Sets are designed for use with the company's benchtop GS Junior and GS FLX next-generation sequencing systems–enabling high-resolution typing and unambiguous allele assignment in a single run.

The kits are the first in a series of assays in the areas of immunogenetics, infectious disease, and cancer to be launched for use with 454 Sequencing Systems, allowing scientists to integrate easily the platforms into application-specific laboratory workflows.

The HLA genes encode for the immune system proteins that recognize foreign cells and other antigens. More...
Accurate characterization of an individual's HLA type is important for tissue transplantation matching, while variations in these genes have known association with a wide variety of autoimmune diseases, infectious diseases, and some cancers.

The long, clonal reads provided by 454 Sequencing Systems enable straightforward high-resolution of multiple samples at a time. In many cases HLA typing achieves unambiguous allele identification within a single sequencing run. Sequence output is compatible with third party HLA genotyping software tools – offering scientists a complete solution from DNA to genotype assignment.

Genotyping of HLA genes can be challenging because of the highly polymorphic nature of this region of the human genome. Traditional sequence-based typing using Sanger capillary electrophoresis technology is unable to resolve ambiguities and set phase without requiring multiple iterations, interspersed with significant manual analysis of the data, and often the use of multiple technologies.

The GS GType HLA Primer Sets are the result of an extensive multisite study, which was published March, 2011 in the journal Tissue Antigens.

"454Sequencing Systems offer a major advance for high-resolution, high-throughput HLA typing,” explained Henry Erlich, PhD, senior study author and Director of the Department of Human Genetics at Roche Molecular Systems. "The ability to quickly achieve such high accuracy and resolution will have a significant impact on research and, ultimately, on clinical application of HLA typing.”

Related Links:
454 Life Sciences


Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
HPV Test
Allplex HPV28 Detection
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.